[Federal Register Volume 80, Number 25 (Friday, February 6, 2015)]
[Notices]
[Pages 6722-6724]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-02328]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-15-0964]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC), as part of
its continuing effort to reduce public burden and maximize the utility
of government information, invites the general public and other Federal
agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. To request more information on the below
proposed project or to obtain a copy of the information collection plan
and instruments, call 404-639-7570 or send comments to Leroy A.
Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an
email to [email protected].
Comments submitted in response to this notice will be summarized
and/or included in the request for Office of Management and Budget
(OMB) approval. Comments are invited on: (a) Whether the proposed
collection of information is necessary for the proper performance of
the functions of the agency, including whether the information shall
have practical utility; (b) the accuracy of the agency's estimate of
the burden of the proposed collection of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology; and (e)
estimates of capital or start-up costs and costs of operation,
maintenance, and purchase of services to provide information. Burden
means the total time, effort, or financial resources expended by
persons to generate, maintain, retain, disclose or provide information
to or for a Federal agency. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information; and to transmit or otherwise
disclose the information. Written comments should be received within 60
days of this notice.
Proposed Project
Interventions to Reduce Shoulder MSDs in Overhead Assembly (OMB No.
0920-0964, expires 4/30/2015)--Extension--National Institute for
Occupational Safety and Health (NIOSH), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The mission of the National Institute for Occupational Safety and
Health (NIOSH) is to promote safety and health at work for all people
through research and prevention. Under Public Law 91-596, sections 20
and 22 (Section 20-22, Occupational Safety and Health Act of 1970),
NIOSH has the responsibility to conduct research to advance the health
and safety of workers. In this capacity, NIOSH proposes a three year
extension
[[Page 6723]]
for a study to assess the effectiveness and cost-benefit of
occupational safety and health interventions to prevent musculoskeletal
disorders (MSDs) among workers in the Manufacturing (MNF) sector.
An extension is requested for this ICR because only one quarter of
the necessary sample size was enrolled during the previous cycle. The
eligible employee population will be expanded to include other
Departments at the facility to achieve the necessary sample size. It is
believed that the targeted number of interventions, which was not
achieved in the previous year, can be achieved by expanding to
additional Departments.
Musculoskeletal disorders (MSDs) represent a major proportion of
injury/illness incidence and cost in the U.S. Manufacturing (MNF)
sector. In 2008, 29% of non-fatal injuries and illnesses involving days
away from work (DAW) in the MNF sector involved MSDs and the MNF sector
had some of the highest rates of MSD DAW cases. The rate for the motor
vehicle manufacturing sub-sector (NAICS 3361) was among the highest of
MNF sub sectors, with MSD DAW rates that were higher than the general
manufacturing MSD DAW rates from 2003-2007.
In automotive manufacturing, overhead conveyance of the vehicle
chassis requires assembly line employees to use tools in working
postures with the arms elevated. These postures are believed to be
associated with symptoms of upper limb discomfort, fatigue, and
impingement syndromes (Fischer et al., 2007). Overhead working posture,
independent of the force or load exerted with the hands, may play a
role in the development in these conditions.
Recent studies suggest a more significant role of localized
shoulder muscle fatigue in contributing to these disorders. Fatigue of
the shoulder muscles may result in changes in normal shoulder
kinematics (motion) that affect risk for shoulder impingement disorders
(Ebaugh et. al., 2006; Chopp et al., 2010).
The U.S. Manufacturing sector has faced a number of challenges
including an overall decline in jobs, an aging workforce, and changes
in organizational management systems. Studies have indicated that the
average age of industrial workers is increasing and that older workers
may differ from younger workers in work capacity, injury risk, severity
of injuries, and speed of recovery (Kenny et al., 2008; Gall et al.,
2004; Restrepo et al., 2006). As the average age of the industrial
population increases and newer systems of work organization (such as
lean manufacturing) are changing the nature of labor-intensive work,
prevention of MSDs will be more critical to protecting older workers
and maintaining productivity.
This study will evaluate the efficacy of two intervention
strategies for reducing musculoskeletal symptoms and pain in the
shoulder attributable to overhead assembly work in automotive
manufacturing. These interventions are, (1) an articulating spring-
tensioned tool support device that unloads from the worker the weight
of the tool that would otherwise be manually supported, and, (2) a
targeted exercise program intended to increase individual employees'
strength and endurance in the shoulder and upper arm stabilizing muscle
group. As a primary prevention strategy, the tool support engineering
control approach is preferred; however, a cost-efficient opportunity
exists to concurrently evaluate the efficacy of a preventive exercise
program intervention. Both of these intervention approaches have been
used in the Manufacturing sector, and preliminary evidence suggests
that both approaches may have merit. However, high quality evidence
demonstrating their effectiveness, by way of controlled trials, is
lacking.
This project will be conducted as a partnership between NIOSH and
Toyota Motors Engineering & Manufacturing North America, Inc. (TEMA),
with the intervention evaluation study taking place at the Toyota Motor
Manufacturing Kentucky, Inc. (TMMK) manufacturing facility in
Georgetown, Kentucky.
The prospective intervention evaluation study will be conducted
using a group-randomized controlled trial multi-time series design.
Four groups of 25-30 employees will be established to test the two
intervention treatment conditions (tool support, exercise program), a
combined intervention treatment condition, and a control condition. The
four groups will be comprised of employees working on two vehicle
assembly lines in different parts of the facility, on two work shifts
(first and second shift).
Individual randomization to treatment condition is not feasible, so
a group-randomization (by work unit) will be used to assign the four
groups to treatment and control conditions.
Observations will be made over the 10-month study period and
questionnaires will include the Shoulder Rating Questionnaire (SRQ),
Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, a
Standardized Nordic Questionnaire for body part discomfort, and a Work
Organization Questionnaire. In addition to the monthly questionnaires,
a shoulder-specific functional capacity evaluation test battery will be
administered pre- and post-intervention, to confirm the efficacy of the
targeted exercise program in improving shoulder capacity.
In summary, this study will evaluate the effectiveness of two
interventions to reduce musculoskeletal symptoms and pain in the
shoulder associated with repetitive overhead work in the manufacturing
industry. The evidence-based prevention practices that may result from
this associated research project will be disseminated to the greatest
audience possible.
NIOSH expects to complete data collection in 2015-2016 and there is
no cost to employee respondents, as they will participate in this study
during their normal working hours at their regular wage.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Employees................. PAR-Q (Physical 125 1 2/60 4
Activity Readiness).
Shoulder Rating 125 10 4/60 83
Questionnaire (SRQ).
Disabilities of the 125 10 6/60 125
Arm Shoulder and
Hand (DASH).
Standardized Nordic 125 10 4/60 83
Questionnaire for
Musculoskeletal
Symptoms.
Work Organization 125 3 26/60 163
Questionnaire.
-------------------------------------------------------------------------------------
[[Page 6724]]
Total................. .................... .............. .............. .............. 458
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-02328 Filed 2-5-15; 8:45 am]
BILLING CODE 4163-18-P